By Scientia Professor Vlado Perkovic

Journal articles

Perkovic V; Francis SL; Zhang H; Gao Y; Lv J; Li H; Yan Y; Zhang Y; Liu C; Zhang H; Tian J, 2026, 'Randomized Clinical Trials of Deutaleglitazar in Healthy Participants and in Patients with Diabetic Kidney Disease', Kidney International Reports, 11, http://dx.doi.org/10.1016/j.ekir.2026.107037

Mann JFE; Badve SV; Baeres FMM; Belmar N; Brown-Frandsen K; Buse JB; Colhoun HM; Deanfield JE; Engelmann MDM; Hovingh GK; Idorn T; Lincoff AM; Lingvay I; Mahaffey KW; McGuire DK; Pratley RE; Rasmussen S; Rossing P; Sattar N; Tuttle KR; Perkovic V, 2026, 'Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis', Lancet Diabetes and Endocrinology, 14, pp. 818 - 830, http://dx.doi.org/10.1016/S2213-8587(26)00134-8

Yeung EK; Siriwardana A; Buizen L; Tang AHC; Jun M; Polkinghorne KR; Tang SCW; Kotwal S; Arnott C; Levin A; Jardine M; Lim SK; Jha V; Mahaffey KW; Perkovic V; Heerspink HJL; Neuen BL, 2026, 'Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial', Nephrology Dialysis Transplantation, pp. gfag203, http://dx.doi.org/10.1093/ndt/gfag203

Heerspink HJL; Neuen BL; Agarwal R; Cherney DZI; Lam CSP; Tuttle KR; Wanner C; Sarafidis P; Jongs N; Smeijer JD; Brinker M; Rethemeier N; Schloemer P; Vesterinen P; Goldsbury D; Dizayee S; Mares JW; Perkovic V, 2026, 'Finerenone in Persons with Chronic Kidney Disease without Diabetes', New England Journal of Medicine, 395, pp. 533 - 545, http://dx.doi.org/10.1056/NEJMoa2604625

Heerspink HJL; Arnott C; Barratt J; Campbell KN; Pecoits-Filho R; Fukami K; Halimi J-M; Hou FF; Lam CSP; Levin A; Lindberg M; Kashioulis P; Mercier A-K; Sinsakul M; Ambery P; Perkovic V, 2026, 'Design and baseline characteristics of the ZENITH high proteinuria trial testing zibotentan/dapagliflozin efficacy on CKD progression', Nephrology Dialysis Transplantation, pp. gfag172, http://dx.doi.org/10.1093/ndt/gfag172

Wu J; Kim D; Guo L; Wang J; Yang H; Chen P; Li J; Monaghan H; Wong MG; Perkovic V; Lv J; Zhang H, 2026, 'Hematuria Remission and Prognosis in IgA Nephropathy: A Post Hoc Analysis of the TESTING Randomized Clinical Trial', American Journal of Kidney Diseases, 88, pp. 278 - 281, http://dx.doi.org/10.1053/j.ajkd.2026.02.649

CHATUR S; FLETCHER RA; YEUNG E; SIRIWARDANA A; HEATH L; VADUGANATHAN M; ARNOTT C; BADVE SV; KOTWAL S; JUN M; JARDINE M; POLLOCK C; HEERSPINK HJL; PERKOVIC V; NEUEN BL, 2026, 'Sodium-glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes and Chronic Kidney Disease Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20 mL/min/1.73 m2', Journal of Cardiac Failure, 32, pp. 1408 - 1417, http://dx.doi.org/10.1016/j.cardfail.2026.01.020

Barratt J; Eren N; Kashihara N; Maes B; Rizk DV; Rovin B; Trimarchi H; Zhang H; Wang W; Kocyigit I; Hao C; Tesař V; Turgutalp K; Yang L; Xing G; Duro Garcia V; Han SH; Lu W; Pisani A; Weinmann-Menke J; Eitner F; Guerard N; Butylin D; Monaco L; Scosyrev E; Magirr A; Renfurm R; Hach T; Perkovic V, 2026, 'Iptacopan in IgA Nephropathy - Final 24-Month Data', New England Journal of Medicine, 395, pp. 465 - 477, http://dx.doi.org/10.1056/NEJMoa2600743

Badve SV; Perkovic V; Jha V; Ramachandran R; Mushahar L; Menne J; De Vriese AS; Rossignol P; Flahault A; Al Ammari M; Skhiri H; Walsh M; Collister D; Liew A; Billot L; Bompoint S; Devaux A; Jun M; Lin E; Ramos Da Cruz A; Ha JT; Eikelboom JW; Shaman A; Jardine MJ; Jesudason S; Wong MG; Anderson CS; Garg AX; Heerspink HJL; Monaghan H; Patel A; Mark PB; Wheeler DC; Lv J; Zuo L; Pilmore H; Gallagher M, 2026, 'Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial', JAMA, 336, pp. 296 - 305, http://dx.doi.org/10.1001/jama.2026.9379

Neuen BL; Perkovic V; Agarwal R; Cherney DZI; Lam CSP; Wanner C; Tuttle KR; Sarafidis P; Barratt J; Burgner A; Chen X; Chew-Wong A; Dobronravov VA; Floege J; Mccafferty K; Nangaku M; Packham D; Papachristou E; Pergola PE; Speeckaert MM; Subbiah A; Tang SCW; Tang S; Yeo SC; Jongs N; Smeijer JD; Berger M; Brinker M; Dayoub R; Elliott J; Li N; Mueller K; Rethemeier N; Finkelsztein MY; Heerspink HJL, 2026, 'Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial', JAMA, 336, pp. 224 - 235, http://dx.doi.org/10.1001/jama.2026.9923

Neuen BL; Major RW; Grams ME; Sang Y; Coresh J; Ballew SH; Surapaneni A; Alencar de Pinho N; Ärnlöv J; Arnott C; Bell S; Berry J; Brenner H; Ciemins E; Chang AR; Cushman M; de Lemos JA; Diaz-Tocados JM; Farjat AE; Fletcher RA; Gansevoort RT; Heerspink HJL; Herrington WG; Hong C; Horwitz EJ; Hwang SJ; Jassal SK; Kalra PA; Katz R; Khan SS; Kovesdy CP; Kronenberg F; Lees JS; Lloyd-Jones DM; Mill JG; Naimark DMJ; Ndumele C; Polkinghorne KR; Psaty BM; Schloemer P; Shlipak MG; Shrestha P; Song Z; Staplin N; Steubl D; Vart P; Visseren FLJ; Woodward M; Yamagishi K; Young BA; Sabanayagam C; Valdivielso JM; Giedraitis V; Larsson A; Tangri N; Ascher SB; Vernooij RWM; Baricevic-Jones I; Rengarajan S; Sinha S; Chinnadurai R; Landray M; Baigent C; Chong C; Zhang X; Xue C; Cheng CY; Ilori T; Cheung K; Gutierrez O; Sumida K; Rifkin D; Ix J; Bergstrom J; Medcalf JF; Brunskill NJ; Caus M; Martin-Conde ML; Bermudez-Lopez M; Cambray S; Lambourg E; Livingstone SJ; Palmer C; Pearson E; Saritas T; Schneider M; Bechtel-Walz W; Schultheiss UT; Judge P; Haynes R; Giatti L; de Almeida MDCC; Bensenor I; da Fonseca MDJM; Bracco P; Wang H; Niu M; Engelhard M; Pencina MJ; Shah A, 2026, 'Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals', Nature Medicine, 32, pp. 2629 - 2638, http://dx.doi.org/10.1038/s41591-026-04437-z

Du R; Wallace H; Ha JT; Talbot B; Perkovic V; de Boer IH; Jardine M; Levin A; Górriz JL; Heerspink HL; Kotwal S, 2026, 'Sex disparities in receiving evidence-based medications in patients with CKD', Nephrology Dialysis Transplantation, pp. gfag135, http://dx.doi.org/10.1093/ndt/gfag135

Neuen BL; Heerspink HJL; Perkovic V; Cherney DZI; Lam CSP; Tuttle KR; Wanner C; Sarafidis P; Anker SD; Filippatos G; Pitt B; Rossing P; Ruilope LM; Jongs N; Smeijer JD; Brinker M; Ahlers C; Lage A; Horvat-Bröcker A; Schloemer P; Eissing T; Dayoub R; Lawatscheck R; Agarwal R, 2026, 'Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)', Lancet, 407, pp. 2375 - 2386, http://dx.doi.org/10.1016/S0140-6736(26)01009-3

Tuttle KR; Bakris GL; Baeres FMM; Bang CN; Bax WA; Belmar N; Musinga D; Cherney DZI; Chernin G; Lim SK; Mann JFE; Perkovic V; Pratley R; Ridker PM; Rossing P; Schmieder R; Shamkhalova MS; Sreenivasamurthy L; Mahaffey KW, 2026, 'Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease', Journal of the American College of Cardiology, 87, pp. 2996 - 3012, http://dx.doi.org/10.1016/j.jacc.2026.02.5125

Perkovic A; Webster ER; Ridker PM; Tuttle KR; Perkovic V; Neuen BL, 2026, 'Effects of anti-inflammatory agents on cardiovascular outcomes: A systematic review and meta-analysis of randomised controlled trials', American Journal of Preventive Cardiology, 27, http://dx.doi.org/10.1016/j.ajpc.2026.101642

Rossing P; Perkovic V; Rasmussen S; Mann JFE, 2026, 'Nuances in Interpretation: Assessing the Interaction Between Semaglutide and MRAs in the FLOW Trial', Diabetes Care, 49, pp. e92 - e93, http://dx.doi.org/10.2337/dc26-0466

Neuen BL; Lu H; Vaduganathan M; Ostrominski JW; Claggett BL; McCausland FR; Cunningham JW; Wheeler DC; Jha V; Singh AK; McMurray JJV; Perkovic V; Solomon SD, 2026, 'Iron deficiency and risk of cardiovascular events in CKD: insights from the ASCEND-ND trial', European Journal of Heart Failure, pp. xuag171, http://dx.doi.org/10.1093/ejhf/xuag171

Lv J; Liu L; Wang W; Wang X; Zuraw Q; Perkovic V; Fang J; Zhang H, 2026, 'Telitacicept for IgA Nephropathy - Interim Analysis of a Phase 3 Trial', New England Journal of Medicine, 394, pp. 1916 - 1924, http://dx.doi.org/10.1056/NEJMoa2514415

Tangri N; Neuen BL; Cherney DZ; Tuttle KR; Perkovic V, 2026, 'The authors reply', Kidney International, 109, pp. 1036 - 1037, http://dx.doi.org/10.1016/j.kint.2026.01.027

Canney M; Shan S; Er L; Billot L; Han J; Wong MG; Monaghan H; Hladunewich M; Hooi LS; Jha V; Lv J; Perkovic V; Zhang H; Cattran DC; Barbour SJ; Jha V, 2026, 'A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathy', Kidney International, 109, pp. 738 - 749, http://dx.doi.org/10.1016/j.kint.2025.12.024

Vaughan E; Perkovic V, 2026, 'When “Low-Grade” Is No Longer Low Risk in IgA Nephropathy', Clinical Journal of the American Society of Nephrology, Publish Ahead of Print, http://dx.doi.org/10.2215/CJN.0000001044

Bidel Z; Nazarzadeh M; Canoy D; McEvoy JW; Maimaitiaili R; Chalmers J; Teo KK; Pepine CJ; Davis BR; Rahimi K, 2026, 'Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysis', European Heart Journal, 47, pp. 1649 - 1657, http://dx.doi.org/10.1093/eurheartj/ehaf962

Perkovic V; Trimarchi H; Tesar V; Lafayette R; Wong MG; Barratt J; Suzuki Y; Liew A; Zhang H; Carroll K; Jha V; Quevedo A; Han SH; Praga M; Chacko B; Sahay M; Cheung CK; Kooienga L; Walsh M; Xia J; Fajardo C; Shah L; Hafkin J; Rizk DV, 2026, 'Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial', New England Journal of Medicine, 394, pp. 635 - 646, http://dx.doi.org/10.1056/NEJMoa2512133

Staplin N; Roddick AJ; Neuen BL; Anker SD; Bhatt DL; Butler J; Cherney DZI; Docherty KF; Fletcher RA; Inzucchi SE; Jardine M; Mahaffey KW; McGuire DK; McMurray JJV; Neal B; Packer M; Patel SM; Perkovic V; Sabatine MS; Solomon S; Vaduganathan M; Wanner C; Wheeler DC; Zannad F; Haynes R; Heerspink HJL; Herrington WG; Hernandez AF; James S; Jardine MJ; Solomon SD, 2026, 'Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis', JAMA, 335, pp. 220 - 232, http://dx.doi.org/10.1001/jama.2025.20835

Neuen BL; Fletcher RA; Anker SD; Bhatt DL; Butler J; Cherney DZI; Docherty KF; Inzucchi SE; Jardine MJ; Mahaffey KW; McCausland FR; McGuire DK; McMurray JJV; Neal B; Packer M; Patel SM; Perkovic V; Sabatine MS; Sardell RJ; Solomon SD; Vaduganathan M; Wanner C; Wheeler DC; Zannad F; Haynes R; Staplin N; Herrington WG; Heerspink HJL, 2026, 'SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis', JAMA, 335, pp. 233 - 244, http://dx.doi.org/10.1001/jama.2025.20834

Ridker PM; Baeres FMM; Hveplund A; Engelmann MMD; Hovingh KK; Lincoff MM; Marx N; Navar AM; Sattar N; Tuttle K; Perkovic V, 2026, 'Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial: Interleukin-6 Inhibition and Atherosclerotic Event Rate Reduction', JAMA Cardiology, 11, pp. 89 - 97, http://dx.doi.org/10.1001/jamacardio.2025.4491

Heerspink HJL; Collier WH; Chaudhari J; Miao S; Tighiouart H; Appel GB; Caravaca-Fontán F; Floege J; Hannedouche T; Imai E; Jafar TH; Lewis JB; Li PKT; Locatelli F; Maes BD; Neuen BL; Perkovic V; Perrone RD; Remuzzi G; Schena FP; Wanner C; Greene T; Inker LA, 2026, 'A meta-analysis of albuminuria as a surrogate endpoint for kidney failure', Nature Medicine, 32, pp. 281 - 287, http://dx.doi.org/10.1038/s41591-025-04057-z

HA JT; FLETCHER RA; ARNOTT C; JUN M; KOTWAL SS; PERKOVIC V; BADVE SV; NEUEN BL, 2026, 'Albuminuria, Kidney Function and Heart Failure Risk in Type 2 Diabetes: Participant-level Pooled Analysis from the CANVAS Program and CREDENCE Trial', Journal of Cardiac Failure, 32, pp. 151 - 156, http://dx.doi.org/10.1016/j.cardfail.2025.05.021

Karsten M; Badve SV; Gansevoort RT; Berger SP; Heerspink HJL; Abrahams AC; Billot L; Bon RHACM; Gelens MACJ; Guinness D; Hamilton-Craig C; van Heerebeek L; Hemmelder MH; Houston L; Kozor R; Kuypers DRJ; Monaghan H; Neal B; Neuen BL; Otton J; Perkovic V; Rajwani A; Wang AY; Vervloet MG; Arnott C; Jakulj L; van Etten R; Francois K; Gois P; van der Heijden J; Holt J; Jesudason S; Keung K; Kim YS; Krishnasamy R; Kulkarni H; van der Leeuw J; Makris A; Masterson R; Mather A; Ocak G; Palamuthusingam D; Pedagogos E; Siegert C; Smyth B; Srivastava V; Talaulikar G; Vleut R; Waanders F; Wong G; Wong MG; Wyburn K, 2026, 'Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studies', Clinical Kidney Journal, 19, http://dx.doi.org/10.1093/ckj/sfaf376

Tangri N; Neuen BL; Cherney DZ; Tuttle KR; Perkovic V, 2026, 'From progression to remission: a new paradigm for success in chronic kidney disease', Kidney International, 109, pp. 17 - 21, http://dx.doi.org/10.1016/j.kint.2025.10.004

Tuttle KR; Kanbay M; Alicic RZ; Carrero JJ; Copur S; Navar AM; Neuen BL; Perkovic V; Rossing P; Marx N; Ridker PM, 2026, 'Inflammation as a therapeutic target to improve kidney and cardiovascular outcomes', Nature Reviews Nephrology, http://dx.doi.org/10.1038/s41581-026-01117-6

Pecoits-Filho R; Banerjee D; Jardine MJ; Neuen B; Soler MJ; Ahmed SB; Anderson LJ; Bavanandan S; Bansal S; Burton JO; Carrero JJ; Chang TI; Clase CM; Cobo-Marcos M; Manzano AC; de Boer IH; Greenwood SA; Grams ME; Herrington WG; Heerspink HJL; Jha V; Kotwal SS; Kovesdy CP; Krishnasamy R; Levin A; Madero M; Malik C; Mathew RO; Michos ED; Moorthy M; Navaneethan SD; Perkovic V; Rossing P; Reusch JEB; Robinson BM; Sarnak MJ; Sloan L; Stenvinkel P; Taal MW; Tangri N; Tuttle KR; Viecelli AK; Yee-Moon Wang A; Wheeler DC; Wong MMY; Herzog CA, 2026, 'International Society of Nephrology International Expert Forum: Exploring the Nexus of Cardiovascular-Kidney-Metabolic Health', Kidney International, http://dx.doi.org/10.1016/j.kint.2026.06.044

Zhang H; Perkovic V; Barratt J; Rizk DV; Rovin B; Trimarchi H; Maes B; Merkel T; Desai M; Ansari S; Renfurm R; Hach T; Kashihara N, 2026, 'Iptacopan in Patients With IgA Nephropathy From East Asia', Kidney International Reports, 11, pp. 117 - 128, http://dx.doi.org/10.1016/j.ekir.2025.10.017

Tuttle KR; Mann JFE; Mayrdorfer MM; Rayner B; Pugliese G; Pratley RE; Perkovic V; Mahaffey KW; Kashihara N; Jeppesen OK; Gumprecht J; Correa-Rotter R; Cherney DZI; Bosch-Traberg H; Arici M; Rossing P; Porto A; Oviedo A; Elbert A; Gelersztein E; Chertkoff A; Wassermann A; Quevedo MA; MacIsaac R; Roger S; Phoon R; Kerr P; Ajani A; Tan SJ; Colquhoun D; Mather A; Gillard P; De Block C; Debroye C; Duyck F; Krzesinski JM; Lapauw B; Preumont V; Vercammen C; Kamenov BZ; Bobeva R; Levterov G; Gerilovska S; Yabrudi N; Stoyanovska-Elencheva B; Nikitov Z; Franco D; Augusto GA; Salles J; Canani L; Krakauer M; Cerqueira MJ; Riella M; Bajaj H; Schlosser R; Ajala B; Aggarwal N; Dumas R; O'Keefe D; Peterson S; Tsoukas G; Tailor C; Tytus R; Akhras R; Khandwala H; Steen O; Carbonneau D; Cha J; Steele A; Bailey G; Berlingieri J; Dzongowski P; Cherney D; Elliott T; Kovacs C; Hamet P; Perkins B; Tennankore K; Gupta A; Ji L; Li Y; Yuan G; Dong X; Cariou B; Clavel S; Marchand L; Reznik Y; Moulin P; Legrand E; Tricaud IB; Gourdy P; Zaoui P; Monier A; Kazes I; Dahl D; Esser M; Krüger T; Rose L; Schmieder R; Segner A, 2026, 'Kidney and Survival Outcomes with Semaglutide by CKD Severity in the FLOW Trial', Clinical Journal of the American Society of Nephrology, Publish Ahead of Print, http://dx.doi.org/10.2215/CJN.0000000974

Badve SV; Al Ammari M; Anderson CS; Billot L; Bompoint S; Collister D; De Vriese AS; Eikelboom JW; Flahault A; Garg AX; Ha JT; Heerspink HJL; Jardine MJ; Jesudason S; Jha V; Jun M; Landrigan J; Liew A; Lin E; Lv J; Mark PB; Menne J; Monaghan H; Mushahar L; Patel A; Pilmore H; Perkovic V; Ramachandran R; Rossignol P; Shaman A; Skhiri H; Walsh M; Wheeler DC; Wong MG; Zuo L; Gallagher M, 2026, 'Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial', American Journal of Nephrology, pp. 1 - 11, http://dx.doi.org/10.1159/000550796

Shi S; Roberts ISD; Wang Z; Jiang L; Tang C; Wang J; Lv J; Wong MG; Barbour SJ; Perkovic V; Cattran D; Zhang H; Zhang H; Perkovic V; Agarwal R; Barbour S; Cattran D; Cass A; Chan TM; Feehally J; Floege J; Glassock R; Hladunewich MA; SeongHooi L; Jardine MJ; Jha V; Johnson DW; Levin A; Liu ZH; Lv J; Monaghan H; Reich H; Remuzzi G; Wheeler DC; Woodward M; Wu Y; Zhao M, 2026, 'Predictive Value of the Oxford Classification for the Effect of Glucocorticoid Therapy in IgA Nephropathy', Journal of the American Society of Nephrology, 37, pp. 150 - 159, http://dx.doi.org/10.1681/ASN.0000000796

Perkovic V; Cherney D; Erazo-Tapia E; Gerward S; Waechter S; Sahay M; Marx N, 2026, 'The Role of Inflammation and High-Sensitivity C-Reactive Protein in Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease: The FLAME-ASCVD Survey among Nephrologists', Cardiorenal Medicine, pp. 14 - 24, http://dx.doi.org/10.1159/000550094

Perkovic V; Barratt J; Liew A; Jha V; Rizk D; Floege J; Reich H; Yang W; Shah M; Beckett V; Jones N; Alenizi S; Schwartz B; Patel U; Lafayette R, 2026, 'Abstract No: 307 PREVAIL: A PHASE 3 TRIAL OF FELZARTAMAB IN ADULTS WITH IgA NEPHROPATHY', Kidney International Reports, 11, pp. 106952, http://dx.doi.org/10.1016/j.ekir.2026.106952

Yeung E; Siriwardana A; Buizen L; Tang A; Heath L; Jun M; Tang S; Kotwal S; Arnott C; Levin A; Jardine M; Mahaffey K; Perkovic V; Heerspink H; Neuen B, 2026, 'WCN26-2797 Impact of Polypharmacy on the Efficacy and Safety of SGLT2 Inhibitors in Patients with Chronic Kidney Disease: Insights from the CREDENCE trial', Kidney International Reports, 11, pp. 104597, http://dx.doi.org/10.1016/j.ekir.2026.104597

Fan L; Wong MG; Chen W; Ye Z; Jardine M; Badve S; Billot L; Tan N; Monaghan H; Chen M; Coggan S; Kotwal S; Ma G; Perkovic V; Yu X, 2026, 'WCN26-5467 ASPIrin to Reduce Events in Dialysis (ASPIRED) trial: a pragmatic, registry-based, double-blind randomized clinical trial', Kidney International Reports, 11, pp. 104237 - 104237, http://dx.doi.org/10.1016/j.ekir.2026.104237

Tang HA; Yeung EK; Siriwardana A; Buizen L; Tang SCW; Jun M; Kotwal S; Arnott C; Cherney DZ; Neal B; Perkovic VP; Heerspink HJ; Neuen BL, 2026, 'WCN26-7232 EFFECTS OF CANAGLIFLOZIN ON BETA-CELL FUNCTION AND INSULIN RESISTANCE IN TYPE 2 DIABETES MELLITUS: DATA FROM THE CANVAS TRIAL', Kidney International Reports, 11, pp. 104640, http://dx.doi.org/10.1016/j.ekir.2026.104640

Kim D; Neuen BL; Perkovic V; Wong MG, 2025, 'Effects of Therapies on Proteinuria and eGFR in IgA Nephropathy', Clinical Journal of the American Society of Nephrology, 20, pp. 1753 - 1766, http://dx.doi.org/10.2215/CJN.0000000839

Perkovic V; Barratt J; Lafayette R; Liew A; Suzuki Y; Carroll K; Cheung CK; Tesař V; Trimarchi H; Wong MG; Zhang H; Xia J; Fajardo C; Shah L; Hafkin J; Rizk DV, 2025, 'Evaluating Sibeprenlimab in IgA Nephropathy - Rationale and Baseline Data from the VISIONARY Trial', Kidney International Reports, 10, pp. 4207 - 4218, http://dx.doi.org/10.1016/j.ekir.2025.09.031

Zan J; Li J; Wong MG; Kim D; Shi S; Monaghan H; Perkovic V; Lv J; Zhang H, 2025, 'Role of Systemic Glucocorticoids in Reducing IgA and Galactose-Deficient IgA1 Levels in IgA Nephropathy', Clinical Journal of the American Society of Nephrology, 20, pp. 1564 - 1570, http://dx.doi.org/10.2215/CJN.0000000816

Chatur S; Heath L; Fletcher RA; Arnott C; Badve SV; Kotwal S; Vaduganathan M; Jun M; Jardine M; Heerspink H; Perkovic V; Neuen B, 2025, 'Canagliflozin in patients with type 2 Diabetes and CKD experiencing deterioration in eGFR to <20 ml/min/1.73m2 in the CREDENCE Trial', European Heart Journal, 46, http://dx.doi.org/10.1093/eurheartj/ehaf784.4190

Rossing P; Bakris G; Perkovic V; Pratley R; Tuttle KR; Mahaffey KW; Idorn T; Belmar N; Bosch-Traberg H; Rasmussen S; Busch RS; Schmieder RE; Gillard P; Mann JFE, 2025, 'Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis', Diabetes Care, 48, pp. 1878 - 1887, http://dx.doi.org/10.2337/dc25-0472

Nguyen TN; Yu J; Perkovic V; Arnott C; Lindley RI, 2025, 'REPLY: The Assessment Approach of Frailty May Influence Its Prognostic Impact Amidst Clinical Trials', Journal of the American Geriatrics Society, 73, pp. 3620 - 3621, http://dx.doi.org/10.1111/jgs.19598

Perkovic V; Tuttle KR; Rossing P; Mann JFE; Idorn T, 2025, 'Response to the letter to the editor entitled “Semaglutide and kidney function: direct kidney protection or an artifact?”', Kidney International, 108, pp. 948 - 950, http://dx.doi.org/10.1016/j.kint.2025.07.008

Kim D; Woodward M; Lv J; Hladunewich MA; Jha V; Hooi LS; Monaghan H; Perkovic V; Zhang H; Wong MG, 2025, 'Sex Differences Across Corticosteroid Response and Outcomes in IgA Nephropathy', Kidney International Reports, 10, pp. 3527 - 3534, http://dx.doi.org/10.1016/j.ekir.2025.07.041

Ketema DB; Wallace H; Hailu W; Badve SV; Ronksley P; Neuen BL; Pecoits-Filho R; Gallagher M; Kotwal S; Perkovic V; Joshi R; Jun M, 2025, 'Quality of care for people with chronic kidney disease: a systematic review and meta-analysis', BMJ Open, 15, http://dx.doi.org/10.1136/bmjopen-2025-102044

Back to profile page